Skip to content
BIORCHESTRA
  • Science
    • Our Scientific Approach
    • Publications
  • Pipeline
  • About Us
    • Leadership
    • Key Facts
    • Our Values
    • Contact Us
  • News
    • Press Releases
    • Media
    • Notice
    • Careers
  • Science
    • Our Scientific Approach
    • Publications
  • Pipeline
  • About Us
    • Leadership
    • Key Facts
    • Our Values
    • Contact Us
  • News
    • Press Releases
    • Media
    • Notice
    • Careers

Avant-garde of RNA Therapeutics We develop novel RNA-based therapeutics that will be able to bring about a paradigm shift for neurodegenerative diseases. Our Journey for RNA therapeutics From novel target discovery to first-in-class drug development, we are dedicated to becoming the pioneers of RNA therapeutics Dicsovery Delivery Clinical Approaches Our Science
We develop RNA-based therapeutics for neuroinflammatory diseases, with a particular focus on comprehensive patient care. We have complementary discovery platforms that cover all the way from diagnosis to treatment monitoring RNA Therapeutics Diagnostic kit
Pipeline The programs in our R&D pipeline are focusing on RNA-based therapeutics that treat neurodegenerative diseases. Each program addresses a target that is validated to cause or increase the risk for neurodegenerative diseases in genetics, cell biology, and bioinformatics Learn more
click the symbol to switch slides